<div id="readability-page-1"><p>We’re driven by a shared mission: to help you live a healthier, fuller life. The revolutionary health technologies and products we create serve that very human purpose. Managing diabetes. Monitoring hearts. Easing chronic pain. Through our products, our science and our partnerships, we work to bring better health to more people, so that our next breakthrough can lead to theirs.</p>    <h2><strong>Current Stock Price:</strong><strong></strong></h2>    <ul> <li>$120.73</li> </ul>    <h2><strong>Market Capitalization:</strong></h2>    <ul> <li>$209.9 billion</li>    <li>Enterprise Value (EV): $215.2 billion</li> </ul>    <h2><strong>Valuation:</strong></h2>    <ul> <li>Trailing P/E: 15.2</li>    <li>Forward P/E: 21.8</li>    <li>Indicates ABT’s earnings relative to its price are moderate compared with many large healthcare peers.</li>    <li><strong>Growth-Adjusted Valuation</strong> <ul> <li>PEG Ratio: 2.26 (higher number suggests slower expected growth relative to current valuation).</li> </ul> </li>    <li><strong>Sales &amp; Cash Flow Multiples</strong><ul><li>P/S (Price/Sales): ~4.8</li></ul><ul><li>P/B (Price/Book): ~4.1</li></ul><ul><li>P/FCF (Price/Free Cash Flow): ~30.4</li></ul> <ul> <li>EV/EBITDA: ~18.3</li> </ul> </li> </ul>        <p>The post Abbott Laboratories achieves double-digit earnings growth first appeared on AlphaStreet.</p></div>

<p>Abbott Laboratories reported double-digit earnings growth, driven by its mission to enhance health through innovative technologies and products. The company's current stock price is $120.73, with a market capitalization of $209.9 billion and an enterprise value of $215.2 billion. Its trailing P/E ratio is 15.2, while the forward P/E is 21.8, indicating moderate earnings relative to price. The PEG ratio stands at 2.26, suggesting slower expected growth compared to its valuation. Other financial metrics include P/S at ~4.8, P/B at ~4.1, and EV/EBITDA at ~18.3.</p>

Alpha Street

iShares Global Healthcare

Abacus Global

iShares US Pharma

SPDR S&P Health Equip

Abbott Laboratories

VG Health

Health Care Select Sector SPDR

iShares US Medical Devices

Abbott Laboratories achieves double-digit earnings growth